SIG-003

N/A

Report date: 2023/12/19 14:32:09

Base Information

Drug NameSIG-003
Drug Alias NameSIG-003
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacementsCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSigilon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSigilon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A